Bilimsel çalışmalar

Doç. Dr. Sema Türker

48 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-15725-9 PMID 41691201 Açık erişimli tam metinKaynak: OpenAlex

  2. Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study

    Therapeutic Advances in Medical Oncology, 2026

    DOI 10.1177/17588359261430583 PMID 41835339 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  3. Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15041657 PMID 41753346 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  4. Efficacy of Anti-VEGF and Anti-EGFRs in Microsatellite Instable (MSI-H) Metastatic Colorectal Cancer in a Turkish Oncology Group (TOG) Cohort Study

    Current Oncology, 2025

    DOI 10.3390/curroncol32110639 PMID 41294701 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  5. Prognostic impact of hand-foot skin reaction in regorafenib-treated adult-type diffuse gliomas: A multicenter Turkish Oncology Group study

    Scientific Reports, 2025

    DOI 10.1038/s41598-025-19899-3 PMID 41102268 Açık erişimli tam metinKaynak: OpenAlex

  6. Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study

    Journal of Chemotherapy, 2024

    DOI 10.1080/1120009x.2024.2366683 PMID 38904164 1 atıf (Europe PMC) Kaynak: OpenAlex

  7. The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing

    Journal of Chemotherapy, 2024

    DOI 10.1080/1120009x.2024.2305066 PMID 38263804 2 atıf (Europe PMC) Kaynak: OpenAlex

  8. Systemic Treatment of Esophageal Cancer

    Springer eBooks, 2024

    DOI 10.1007/978-3-031-47024-0_45 Kaynak: OpenAlex

  9. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

    BMC Cancer, 2023

    DOI 10.1186/s12885-023-10609-8 PMID 36765293 18 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  10. PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study

    Journal of Geriatric Oncology, 2023

    DOI 10.1016/j.jgo.2023.101604 PMID 37683369 10 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  11. The Effect of HER2-Low Status on Pathological Complete Response and Survival in Triple-Negative Breast Cancer: A Systemic Review and Meta-Analysis

    Clinical Breast Cancer, 2023

    DOI 10.1016/j.clbc.2023.05.015 PMID 37336652 10 atıf (Europe PMC) Kaynak: ORCID

  12. First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal carcinoma

    Bosnian Journal of Basic Medical Sciences, 2022

    DOI 10.17305/bjbms.2021.7069 PMID 35460397 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  13. Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group)

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022

    DOI 10.55730/1300-0144.5404 PMID 36326360 6 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  14. Current Topics In Hemato-Oncology

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1576 Açık erişimli tam metinKaynak: ORCID

  15. Acrometastasis of Laryngeal Carcinoma to the Finger

    Journal of the College of Physicians and Surgeons Pakistan, 2022

    DOI 10.29271/jcpsp.2022.supp1.s55 PMID 35633013 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  16. Acrometastasis of Laryngeal Carcinoma to the Finger

    Journal of College of Physicians and Surgeons Pakistan, 2022

    DOI 10.29271/jcpsp.2022.jcpspcr.cr55 Kaynak: ORCID

  17. Toraks Tümörleri

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1073 Açık erişimli tam metinKaynak: OpenAlex

  18. Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group

    Journal of Gastrointestinal Cancer, 2021

    DOI 10.1007/s12029-021-00594-1 PMID 33538958 4 atıf (Europe PMC) Kaynak: OpenAlex

  19. Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study

    Cancer Investigation, 2021

    DOI 10.1080/07357907.2021.2017952 PMID 34894960 3 atıf (Europe PMC) Kaynak: OpenAlex

  20. COVID-19 ve Kanser

    Akademisyen Kitabevi eBooks, 2021

    DOI 10.37609/akya.668 Kaynak: ORCID

  21. Efficacy and Safety of Neoadjuvant Immunotherapy in Triple Negative Breast Cancer: Meta-analysis of randomized controlled trials

    ResearchSquare, 2021

    DOI 10.21203/rs.3.rs-283259 Kaynak: ORCID

  22. The impact of lymph node ratio on overall survival in patients with colorectal cancer

    Journal of Cancer Research and Therapeutics, 2021

    DOI 10.4103/jcrt.jcrt_11_19 PMID 34528566 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  23. The prognostic role of ab0 blood groups in pancreas cancer

    Eastern Journal of Medicine, 2021

    DOI 10.5505/ejm.2021.03360 Açık erişimli tam metinKaynak: ORCID

  24. The relation between inflammation-based parameters and survival in metastatic pancreatic cancer

    Journal of Cancer Research and Therapeutics, 2021

    DOI 10.4103/jcrt.jcrt_773_19 PMID 34121700 10 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  25. Efficacy and Safety of Neoadjuvant Immunotherapy in Triple Negative Breast Cancer: Meta-analysis of randomized controlled trials

    Research Square, 2021

    DOI 10.21203/rs.3.rs-283259/v1 Açık erişimli tam metinKaynak: OpenAlex

  26. Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer

    Tumori Journal, 2020

    DOI 10.1177/0300891620969823 PMID 33167790 4 atıf (Europe PMC) Kaynak: OpenAlex

  27. Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey.

    PubMed, 2020

    PMID 33099930 5 atıf (Europe PMC) Kaynak: OpenAlex

  28. Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey

    Bursa Uludag University - AVESIS, 2020

    Kaynak: OpenAlex

  29. Worse patient–physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)

    European Journal of Cancer Care, 2020

    DOI 10.1111/ecc.13296 PMID 32864838 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  30. The hematologic inflammatory index is a new prognostic marker in patients resected for gastric cancer.

    Journal of cancer research and therapeutics, 2020

    DOI 10.4103/jcrt.jcrt_560_19 PMID 33380669 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  31. Predictors of Neoplasia in Colonic Wall Thickening Detected via Computerized Tomography.

    Cureus, 2020

    DOI 10.7759/cureus.10553 PMID 32968607 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  32. Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment.

    Journal of cancer research and therapeutics, 2020

    DOI 10.4103/jcrt.jcrt_343_17 PMID 32719294 5 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  33. Tumor‐to‐tumor metastasis: Breast cancer metastasis to lung cancer

    The Breast Journal, 2020

    DOI 10.1111/tbj.13558 PMID 31565825 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  34. The Relationship Between Primary Tumor Localization and Driver Mutation in Lung Cancer

    Eurasian Journal of Medicine and Oncology, 2020

    DOI 10.14744/ejmo.2020.13543 Açık erişimli tam metinKaynak: ORCID

  35. The prognostic value of the red cell distribution width to platelet count ratio in patients with breast cancer,Meme kanserli hastalarda kırmızı küre dağılım genişliğinin trombosit sayısına oranının prognostik değeri

    Turkiye Klinikleri Journal of Medical Sciences, 2020

    DOI 10.5336/medsci.2019-71722 Açık erişimli tam metinKaynak: ORCID

  36. AKCİĞER KANSERİ EPİDEMİYOLOJİ VE ETYOPATOGENEZİ

    2020

    Kaynak: OpenAlex

  37. Worse patient- physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the palliative care working committee of the Turkish Oncology Group (TOG)

    Annals of Oncology, 2019

    DOI 10.1093/annonc/mdz262.001 Açık erişimli tam metinKaynak: OpenAlex

  38. A new prognostic index in patients with hormone receptor-positive and HER2-negative breast cancer,Nowy wskaźnik prognostyczny u pacjentek z rakiem piersi i ekspresja receptorów hormonalnych oraz brakiem ekspresji HER2

    Current Gynecologic Oncology, 2019

    DOI 10.15557/cgo.2019.0020 Açık erişimli tam metinKaynak: ORCID

  39. Investigation of the severity of depressive symptoms in cancer patients receiving chemotherapy

    Eastern Journal of Medicine, 2019

    DOI 10.5505/ejm.2019.02419 Açık erişimli tam metinKaynak: ORCID

  40. Mean platelet volume to lymphocyte ratio as a novel marker in patients with breast cancer who underwent curative resection,Stosunek sredniej objȩtosci plytek krwi do liczby limfocytów jako nowy marker u chorych na raka piersi po pierwotnym zabiegu operacyjnym

    Current Gynecologic Oncology, 2019

    DOI 10.15557/cgo.2019.0014 Açık erişimli tam metinKaynak: ORCID

  41. Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Systemic Immune-Inflammatory Index in Resected Gastric Cancer

    Journal of Clinical Medicine of Kazakhstan, 2019

    DOI 10.23950/1812-2892-jcmk-00724 Açık erişimli tam metinKaynak: ORCID

  42. Investigation of Clinical Features and the Use of Complementary and Alternative Medicines in Cancer Patients, A Single-Center Experience.

    Acta Oncologica Turcica, 2019

    DOI 10.5505/aot.2019.85579 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  43. "Squamos cell lung cancer" case applying with dyspepsia complaints

    Journal of Oncological Sciences, 2018

    DOI 10.1016/j.jons.2018.08.001 7 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

  44. The relationship between localization and neutrophil lymphocyte ratio in colon carcinoma

    Ortadoğu Tıp Dergisi, 2018

    DOI 10.21601/ortadogutipdergisi.398756 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

  45. ADAM proteases involved in inflammation are differentially altered in patients with gastritis or ulcer

    Experimental and Therapeutic Medicine, 2018

    DOI 10.3892/etm.2017.5619 PMID 29434796 11 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  46. Differential changes in Substance P, VIP as well as neprilysin levels in patients with gastritis or ulcer.

    Peptides, 2012

    DOI 10.1016/j.peptides.2012.03.018 PMID 22484287 17 atıf (Europe PMC) Kaynak: ORCID

  47. Lung involvement in patients with primary Sjögren's syndrome: What are the predictors?

    Rheumatology International, 2010

    DOI 10.1007/s00296-009-1152-8 PMID 19844720 64 atıf (Europe PMC) Kaynak: ORCID

  48. p53 staining as a prognostic indicator in endometrial carcinoma.

    PubMed, 1999

    PMID 10376438 11 atıf (OpenAlex) Kaynak: OpenAlex